Skip to Content


In the US, Edoxaban (edoxaban systemic) is a member of the drug class factor Xa inhibitors and is used to treat Atrial Fibrillation, Deep Vein Thrombosis, Prevention of Thromboembolism in Atrial Fibrillation and Pulmonary Embolism.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Anticoagulant agent

Chemical Name

N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(N,N-dimetylcarbamoyl)-2-(5-metyl-4,5,6,7-tetrahydro[1,3]tiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide (WHO)

Foreign Names

  • Edoxabanum (Latin)
  • Edoxaban (German)
  • Édoxaban (French)
  • Edoxabán (Spanish)

Generic Names

Brand Names

  • Lixiana
    Daiichi, Greece; Daiichi Sankyo, Spain; Daiichi Sankyo, Norway; Daiichi Sankyo, Slovenia; Daiichi Sankyo, Turkey; Daiichi Sankyo Europe, Lithuania
  • Lixiana 30 mg
    Daiichi Sankyo, Hungary
  • Lixiana 60 mg
    Daiichi Sankyo, Hungary
  • Roteas
    Daiichi Sankyo, Latvia
  • Lixiana
    Daiichi Sankyo, Estonia; Daiichi Sankyo, Japan; Daiichi Sankyo Europe GmbH, Netherlands
  • Lixiana 15mg
    Daiichi Sankyo, Switzerland
  • Lixiana 30mg
    Daiichi Sankyo, Switzerland
  • Lixiana 60mg
    Daiichi Sankyo, Switzerland
  • Lixiana
    Daiichi Sankyo, Belgium; Daiichi Sankyo, Czech Republic; Daiichi Sankyo, Germany; Daiichi Sankyo, Ireland; Daiichi Sankyo, Iceland; Daiichi Sankyo, Portugal; Daiichi Sankyo, Slovakia; Daiichi Sankyo UK, United Kingdom; MSD, Denmark; MSD, Finland; MSD, Sweden; Servier, Canada
  • Lixiana 15mg
    Daiichi Sankyo, Luxembourg; Daiichi Sankyo Europe, Austria
  • Lixiana 30mg
    Daiichi Sankyo, Luxembourg; Daiichi Sankyo Europe, Austria
  • Lixiana 60mg
    Daiichi Sankyo, Luxembourg; Daiichi Sankyo Europe, Austria
  • Roteas
    Daiichi Sankyo, Estonia; Daiichi Sankyo Europe, Sweden
  • Savaysa
    Daiichi Sankyo, United States


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.